Related Experiment Videos
An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs
C Sheridan1, G Brumatti, M Elgendy
1Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin, Ireland.
Abstract:
Cisplatin is a widely used cancer chemotherapeutic that promotes DNA damage-associated apoptosis. Although platinum compounds are known to form DNA adducts and provoke DNA damage, the molecular mechanism of cisplatin-induced cell death remains unclear. In this article, we show that the BH3-only protein Noxa is strongly transcriptionally upregulated in response to cisplatin and related platinum compounds. Cisplatin-induced Noxa expression was ERK dependent, but p53 independent, and inhibition of ERK activation markedly attenuated cisplatin-induced cell death, as well as Noxa expression. Furthermore, siRNA-mediated ablation of Noxa expression also inhibited cisplatin-induced cell death and permitted clonogenic survival. These observations reveal a novel ERK-regulated route to Noxa expression that is important for the cell killing activity of platinum-based chemotherapeutic drugs.
Insights
Cisplatin chemotherapy triggers cancer cell death through a novel pathway involving the BH3-only protein Noxa. This ERK-dependent route to Noxa expression is crucial for the efficacy of platinum-based drugs.
Area of Science:
- Molecular biology
- Cancer research
- Cell death pathways
Background:
- Cisplatin is a platinum-based chemotherapy agent that induces apoptosis.
- The precise molecular mechanisms of cisplatin-induced cell death are not fully understood.
- DNA adduct formation is a known effect of platinum compounds.
Purpose of the Study:
- To elucidate the molecular mechanism of cisplatin-induced apoptosis.
- To investigate the role of the BH3-only protein Noxa in response to cisplatin.
- To identify signaling pathways regulating Noxa expression after cisplatin treatment.
Main Methods:
- Transcriptional analysis of Noxa expression in response to cisplatin.
- Investigating the involvement of ERK and p53 pathways.
- Using siRNA to ablate Noxa expression.
- Assessing cell death and clonogenic survival.
Main Results:
- Cisplatin strongly upregulates Noxa transcription in a manner dependent on ERK activation but independent of p53.
- Inhibition of ERK activation significantly reduces cisplatin-induced cell death and Noxa expression.
- Ablation of Noxa expression using siRNA impairs cisplatin-induced cell death and clonogenic survival.
Conclusions:
- A novel signaling pathway involving ERK-regulated Noxa expression is identified.
- This pathway is critical for the cytotoxic effects of platinum-based chemotherapeutic drugs.
- Targeting this ERK-Noxa axis may offer new therapeutic strategies in cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...